Navigation Links


subsidiary at medicine technology

Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs

...ietary product of MPM Medical, Inc., awholly owned subsidiary of RBC Life Sciences, Inc.(OTCBB:RBCL). MPM Medical develops and markets a line of prescription andnonprescription products for wound management, throughmedical-surgical dealers, to nursing homes, hospitals, and cancerclinics. The statements above,...

Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis

... Inc., based in Ridgefield,CT, is the largest U.S. subsidiary of Boehringer IngelheimCorporation (Ridgefield, CT) and a member of the BoehringerIngelheim group of companies. The Boehringer Ingelheim group is one of the world's 20 leadingpharmaceutical companies. Headquartered in Ingelheim, Germany, itoperates ...

YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy

...zumab has beensub-licensed by CIMYM BioSciences, a subsidiary of YM, to DaiichiSankyo Co., Ltd for Japan and to other companies advancing the drugincluding Oncoscience AG in Europe, Kuhnil in South Korea andInnogene Kalbiotech in Southeast Asia. Nimotuzumab is approved forsale in India and China as well as cert...

Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

...rition and high-tech materials. BayerHealthCare, a subsidiary of Bayer AG, is one of the world’sleading, innovative companies in the healthcare and medicalproducts industry and is based in Leverkusen, Germany.The companycombines the global activities of the Animal Health, Consumer Care,Diabetes Care and P...

Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkin's Lymphoma

...nternational, Inc. (OTCBB: BVTI), a majority owned subsidiary ofAccentia Biopharmaceuticals, Inc. (NASDAQ:ABPI), announced on June27, 2007 blinded interim data from the start of its fast-trackedpivotal Phase 3 clinical trial of BiovaxID(TM) for Non-Hodgkin'slymphoma (NHL) from September 2000 through June 2006. ...

CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS

...d RXi Pharmaceuticals Corporation,a majority-owned subsidiary of CytRx, is a biopharmaceuticalresearch and development company that focuses on developingRNAi-based therapeutics for the treatment of human disease. RXi'sinitial focus is on neurodegenerative diseases, oncology, type 2diabetes and obesity. RXi has ...

CytRx Announces Clinical Results from Its Rising Multiple Dose Trial with Arimoclomol for ALS

...d RXi Pharmaceuticals Corporation,a majority-owned subsidiary of CytRx, is a biopharmaceuticalresearch and development company that focuses on developingRNAi-based therapeutics for the treatment of human disease. RXi'sinitial focus is on neurodegenerative diseases, oncology, type 2diabetes and obesity. RXi has ...

MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions

...rmaceuticals North America,Inc., is a wholly owned subsidiary of Takeda Pharmaceutical CompanyLimited, the largest pharmaceutical company in Japan. In the UnitedStates, Takeda currently markets oral products for diabetes,insomnia, wakefulness and gastroenterology. Through the TakedaGlobal Research & Develop...

Pharmexa A/S (DK) - Pharmexa presents data from influenza program

Summary: Pharmexa-Epimmune, the U.S.-based subsidiary ofPharmexa A/S, presents selected data from its in...rk, June 21, 2007-Pharmexa-Epimmune, theU.S.-based subsidiary of Pharmexa A/S, presented selected data fromits influenza vaccine program today at the Influenza Co...

New Data Presented on Micardis (Telmisartan) Tablets in Hypertensive Patients With Type 2 Diabetes

... Inc., based in Ridgefield,CT, is the largest U.S. subsidiary of Boehringer IngelheimCorporation (Ridgefield, CT) and a member of the BoehringerIngelheim group of companies. The Boehringer Ingelheim group is one of the world's 20 leadingpharmaceutical companies. Headquartered in Ingelheim, Germany, itoperates ...

Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -

...ma.com/">www.QuigleyPharma.com , a whollyowned subsidiary of The Quigley Corporation announced today that ithas completed a follow-up study to evaluate the impact of QR-443 onlevels of a pro-inflammatory cytokine Interleukin-6 (IL-6) in acachexia model. This new data concluded that responding mice hadlower ...

Remicade Two Year Data in Ankylosing Spondylitis Show Improvement in Spinal Mobility and Spinal Inflammation

... immune disorders. Centocor,Inc. is a wholly owned subsidiary of Johnson & Johnson. This press release contains "forward-looking statements" asdefined in the Private Securities Litigation Reform Act of 1995.These statements are based on current expectations of futureevents. If underlying assumptions prove ...

Study Demonstrated Rozerem (ramelteon) Does Not Affect Middle-of-the-Night Balance in Older Adults with Insomnia

...rmaceuticals North America,Inc., is a wholly owned subsidiary of Takeda Pharmaceutical CompanyLimited, the largest pharmaceutical company in Japan. In the UnitedStates, Takeda currently markets products for diabetes, insomnia,wakefulness and gastroenterology. Through the Takeda GlobalResearch & Development ...

Enbrel Safety Data for up to Eight Years in Patients with Juvenile Rheumatoid Arthritis Being Presented at EULAR

... NorthAmerica. Immunex Corporation, a wholly owned subsidiary of Amgen,manufactures ENBREL. Additional information about ENBREL, includingthe full U.S. Prescribing Information, can be found on the Web sitesponsored by the companies at www.enbrel.com or by calling, in theU.S., toll free 888-4ENBREL (888-436-2735...

Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine

...twork)-- Endo Pharmaceuticals Inc., a wholly owned subsidiary of EndoPharmaceuticals Holdings Inc. (NASDAQ: ENDP...st pain, anddyspepsia. About Endo A wholly owned subsidiary of Endo Pharmaceuticals Holdings Inc.,Endo Pharmaceuticals is a fully integrated specialty pharmaceu...

Promising Data on Cognitive Effects of Safinamide in Early Parkinson's Disease

...n the remaining approximately 30%. In 1917 theU.S. subsidiary Merck & Co. was expropriated and has been anindependent company ever since....

Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of Erbitux for Colorectal and Head and Neck Cancer Patients

...n the remaining approximately 30%. In 1917 theU.S. subsidiary Merck & Co. was expropriated and has been anindependent company ever since....

Caelyx Delays Time to Disease Progression as Maintenance Therapy in Patients with Metastatic Breast Cancer

... a distribution agreement withALZA, a wholly owned subsidiary of Johnson & Johnson of NewBrunswick, N.J., USA. The product is marketed in the United Statesunder the trade name DOXIL® by Ortho Biotech Products,L.P. Important Safety Information from the U.S. label for DOXIL Myocardial damage may lead to c...

Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)

...ut Eisai Inc. Eisai Inc. is a U.S. pharmaceutical subsidiary of Eisai Co.,Ltd., a research-based human health care (hhc) company thatdiscovers, develops and markets products throughout the world.Eisai focuses its efforts in three therapeutic areas: neurology,gastrointestinal disorders and oncology/critical car...

Merck at ASCO 2007: Encouraging Results in Progression-Free Survival in Patients With Aggressive Brain Tumors (glioblastoma) Using Cilengitide in Phase I/IIa Study

...n the remaining approximately 30%. In 1917 theU.S. subsidiary Merck & Co. was expropriated and has been anindependent company ever since....

Merck at ASCO 2007: New Data Demonstrate the Value of UFT as an Important Treatment Option for Patients With Metastatic Colorectal Cancer

...n the remaining approximately 30%. In 1917 theU.S. subsidiary Merck & Co. was expropriated and has been anindependent company ever since. Contact: Phyllis Carter Phone: +49 (0) 6151 72-7144...

Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting

...icense agreement withPharmion GmbH, a wholly owned subsidiary of Pharmion Corporation,under which Pharmion has b...sried/Munich(Germany), and has a wholly owned U.S. subsidiary headquartered inPrinceton, New Jersey. For additional information, please visit GPCBiotech's Web sit...

Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting

...icense agreement withPharmion GmbH, a wholly owned subsidiary of Pharmion Corporation,under which Pharmion has b...sried/Munich(Germany), and has a wholly owned U.S. subsidiary headquartered inPrinceton, New Jersey. For additional information, please visit GPCBiotech's Web sit...

Clinical Data on Eisai's Oncology Pipeline to be Presented at ASCO Annual Meeting

...ut Eisai Inc. Eisai Inc. is a U.S. pharmaceutical subsidiary of Eisai Co.,Ltd., a research-based human health c...Eisai Medical Research Inc., a U.S. pharmaceutical subsidiary ofEisai Co., Ltd., headquartered in Ridgefield Park, NJ, is focusedon clinical drug development of n...

Generex Biotechnology Vaccine Strategy Presented at International Conference in London

...around the world. Antigen Expressis a wholly owned subsidiary of Generex. The core platformtechnologies of Antigen Express comprise immunotherapeutics for thetreatment of malignant, infectious, allergic, and autoimmunediseases. For more information, visit the Generex website at<a target="_blank" href="http:...

Long-Term Extension of Ulcerative Colitis Study Shows Remicade Responders Maintained Improvement Through Two Years of Follow-Up

... immune disorders. Centocor,Inc. is a wholly owned subsidiary of Johnson & Johnson. About Digestive Disease Week DDW is the largest international gathering of physicians,researchers and academics in the fields of gastroenterology,hepatology, endoscopy and gastrointestinal surgery. Jointlysponsored by the ...

Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)

...eadquartered in Parsippany, New Jersey, isthe U.S. subsidiary of Daiichi Sankyo Co., Ltd., Japan’ssecond largest pharmaceutical company and a global leader inpharmaceutical innovation since 1899. The company isdedicated to the discovery, development and commercialization ofinnovative medicines that impro...

New Study Suggests no Significant Impairment in Middle-of-the-Night Balance, Mobility or Memory in Older Adults Using Ramelteon

...armaceuticals North America,Inc. is a wholly owned subsidiary of Takeda Pharmaceutical CompanyLimited, the largest pharmaceutical company in Japan. In the UnitedStates, Takeda currently markets products for diabetes, insomnia,wakefulness and gastroenterology. Through the Takeda GlobalResearch & Development ...

Phase 2a Diarrhea Predominant Irritable Bowel Syndrome Results from 2006 Presented at Digestive Disease Week in Washington, D.C.

...and is based in South San Francisco, Calif., witha subsidiary in Mumbai, India. Napo's late-stage proprietary gastro-intestinal compound,crofelemer, is in various stages of clinical development for fourdistinct product indications, including a late-stage Phase 3program: -- CRO-HIV for AIDS diarrhoea, Phas...

Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study for Milnacipran as a Treatment for Fibromyalgia Syndrome

... is a registered trademark of Merck Sante s.a.s., subsidiary of Merck KGaA, Darmstadt, Germany. Except for the historical information contained herein, thisrelease contains "forward-looking statements" within the meaning ofthe Private Securities Litigation Reform Act of 1995. Thesestatements involve a nu...

Investigators Report COSTAR II Pivotal Drug-Eluting Stent Trial Results at EuroPCR 2007

... MEDSYSTEMS Conor Medsystems, LLC, a wholly-owned subsidiary of Johnson& Johnson, develops innovative controlled vascular drugdelivery technologies and has primarily focused on the developmentof drug-eluting stents to treat coronary artery disease. Forfurther information about Conor Medsystems and controll...

Enzo Biochem Individualized Oral Immune Regulation Therapy May Be Effective Approach to Treating Crohn's Disease

...ponsored by Enzo Therapeutics,Inc., a wholly owned subsidiary of Enzo Biochem, Inc. (NYSE:ENZ). "Given our current understanding of Crohn's disease as aninappropriate autoimmune response in the GI tract, we aredeveloping Alequel as an individualized oral treatment thatharnesses the patient's own immune system t...

Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term Safety Study of Lialda (mesalamine) Presented at DDW

...by Cosmo Technologies Ltd, Ireland,a wholly- owned subsidiary of Cosmo Pharmaceuticals SpA. Asacol(R) is a registered trademark of Procter & GamblePharmaceuticals. CONTACT: Ashleigh Duchene of GolinHarris for Shire,+1-312-729-4428; orMatthew Cabrey of Shire, +1-484-595-8248 Web site: <a target="_blan...

Additional Efficacy Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at Annual Meeting of American Urological Association

...icense agreement withPharmion GmbH, a wholly owned subsidiary of Pharmion Corporation,under which Pharmion has b...sried/Munich(Germany), and has a wholly owned U.S. subsidiary headquartered inPrinceton, New Jersey. For additional information, please visit GPCBiotech's Web sit...

Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist

...d States, Europe and Asiaoffices, its wholly-owned subsidiary Novatris in France, andthrough a global network of independent market research firms. Theservice bureau, HISB, provides its market research industry clientswith mixed-mode data collection, panel development services, andsyndicated and tracking resear...

Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage 2 Patients Compared With Amlodipine + Benazepril

...eadquartered in Parsippany, New Jersey,is the U.S. subsidiary of Daiichi Sankyo Co., Ltd., Japan's secondlargest... is a registered trademark of Merck Sante s.a.s, subsidiary of Merck KGaA, Darmstadt, Germany. 1. Stage 2 hypertension = systolic blood pressure greate...

Microbia Announces Positive Phase 2 Results for Its Investigational Compound Linaclotide

...robiaPrecision Engineering, Inc., a majority-owned subsidiary ofMicrobia, Inc., is an industrial biotechnology company developingand commercializing novel bioprocesses for the production ofspecialty chemicals, both independently and with strategicpartners. Microbia has raised $231 million in private equityfinan...

New Study Demonstrates that Lubiprostone May Improve Symptom Relief Rates in Adults with Irritable Bowel Syndrome with Constipation (IBS-C)

...armaceuticals North America,Inc. is a wholly owned subsidiary of Takeda Pharmaceutical CompanyLimited, the largest pharmaceutical company in Japan. In the UnitedStates, Takeda currently markets products for diabetes, insomnia,wakefulness and gastroenterology. The company has a robust pipelinewith compounds in d...

Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure as Long-Term Monotherapy and in Combination Therapy

... is a registered trademark of Merck Sante s.a.s., subsidiary of Merck KGaA, Darmstadt, Germany. Except for the historical information contained herein, thisrelease contains "forward-looking statements" within the meaning ofthe Private Securities Litigation Reform Act of 1995. Thesestatements involve a nu...

Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)

...eadquartered in Parsippany, New Jersey,is the U.S. subsidiary of Daiichi Sankyo Co., Ltd., Japan's secondlargest pharmaceutical company and a global leader inpharmaceutical innovation since 1899. The company is dedicated tothe discovery, development and commercialization of innovativemedicines that improve the ...

Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many Aspects of Daily Life

... by Cosmo Technologies Ltd, Ireland,a wholly-owned subsidiary of Cosmo Pharmaceuticals SpA. CONTACT: Media, Amanda Widtfeldt of GolinHarris,+1-312-729-4264, forShire PLC; or Matthew Cabrey of Shire PLC,+1-484-595-8248 Web site: <a target="_blank" href="http://www.shire.com/http://www.UCNORMAL.com/http://w...

Conor Medsystems, LLC Reports COSTAR II Pivotal Drug-Eluting Stent Trial Conclusions

...ona, Spain. Conor Medsystems, LLC, a wholly-owned subsidiary of Johnson& Johnson , develops innovative controlled vascular drugdelivery technologies and has primarily focused on the developmentof drug-eluting stents to treat coronary artery disease. Forfurther information about Conor Medsystems and control...

Treatment with Copaxone Plus Minocycline Showed Substantial Reduction of Disease Activity in Patients with Active Relapsing-Remitting Multiple Sclerosis

... is marketed by Teva Neuroscience, Inc., whichis a subsidiary of Teva Pharmaceutical Industries Ltd(NASDAQ:TEVA). COPAXONE(R) is a registered trademark of TevaPharmaceutical Industries Ltd. Teva Pharmaceutical Industries Ltd., headquartered in Israel, isamong the top 20 pharmaceutical companies in the world an...

Treatment with Copaxone Plus Minocycline Showed Substantial Reduction of Disease Activity in Patients with Active Relapsing-Remitting Multiple Sclerosis

... is marketed by Teva Neuroscience, Inc., whichis a subsidiary of Teva Pharmaceutical Industries Ltd(NASDAQ:TEVA)... is marketed by Teva Neuroscience, Inc., whichis a subsidiary of Teva Pharmaceutical Industries Ltd(NASDAQ:TEVA). COPAXONE(r) is a registered trademark of TevaPha...

Copaxone Treatment over Two Years after Short Term Induction with Mitoxantrone Provided Sustained Benefits to Active Relapsing-Remitting Multiple Sclerosis Patients

... is marketed by Teva Neuroscience, Inc., whichis a subsidiary of Teva Pharmaceutical Industries Ltd(NASDAQ:TEVA). COPAXONE(R) is a registered trademark of TevaPharmaceutical Industries Ltd. Teva Pharmaceutical Industries Ltd., headquartered in Israel, isamong the top 20 pharmaceutical companies in the world an...

Indivumed Study Provides Sound Scientific Basis for a Predictive Drug Test- Platform

...n 2002and headquartered in Hamburg, Germany with a subsidiary inWashington, D.C., Indivumed has cooperation agreements with allmajor oncological hospitals in the Hamburg metropolitan area.Indivumed's current tumor biobank of over 6000 patient-cases,collected with a mean cold ischemia time of less than eightminu...

Immediate Treatment of Early MS Patients with Betaferon Significantly Delayed Permanent Disability

...ual Meeting Bayer HealthCare Bayer HealthCare, a subsidiary of Bayer AG, is one of theworld’s leading, innovative companies in the healthcare andmedical products industry and is based in Leverkusen, Germany. Thecompany combines the global activities of the Animal Health,Consumer Care, Diabetes Care and ...

Phase III Data on Safinamide in Parkinson’s Disease Presented at American Academy of Neurology 59th Annual Meeting

...n the remaining approximately 30%.In 1917 the U.S. subsidiary Merck & Co. was expropriated andhas been an independent company ever since....

Merck Serono Announces Presentation of Phase III Clinical Data on Safinamide in Parkinson’s Disease at the American Academy of Neurology 59th Annual Meeting

...n the remaining approximately 30%.In 1917 the U.S. subsidiary Merck & Co. was expropriated andhas been an independent company ever since....

Positive Results Using Affitech-Identified Human Antibody That Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model Reported by Peregrine

...s and R&Dfacilities in Oslo, Norway and its US subsidiary in the SanFrancisco Bay Area. The Company's current disease focus is oncologyand it utilizes two discrete but unique approaches for thediscovery of fully human antibodies - (i) Molecule Based AntibodyDiscovery, and (ii) Cell Based Antibody Discovery....

CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal

...d RXi Pharmaceuticals Corporation,a majority-owned subsidiary of CytRx Corporation, is abiopharmaceutical research and development company that focuses ondeveloping RNAi-based therapeutics for the treatment of humandisease. RXi's initial focus is on neurodegenerative diseases,oncology, type 2 diabetes and obesi...

Peregrine Pharmaceuticals Highlights Significant Advances in the Company's Clinical and Preclinical Cancer Programs Presented This Week at the AACR Annual Meeting

...manufacturing capabilities through itswholly owned subsidiary Avid Bioservices, Inc. (<a target="_blank"href="http://www.avidbio.com/">www.avidbio.com ), which providesdevelopment and bio-manufacturing services for both Peregrine andoutside customers. Additional information about Peregrine can befound a...

Baxter Presents Phase I Inhaled Insulin Study Results at Respiratory Drug Delivery Conference

...are Corporation is the principal domesticoperating subsidiary of Baxter International Inc. . BaxterInternational Inc., through its subsidiaries, assists healthcareprofessionals and their patients with the treatment of complexmedical conditions, including cancer, hemophilia, immune disorders,kidney disease and t...

Spectrum Pharmaceuticals Announces Data From Three Oncology Programs Presented at the American Association of Cancer Research Annual Meeting

...icense agreement with Pharmion GmbH, a whollyowned subsidiary of Pharmion Corporation, under which Pharmion hasbeen granted exclusive commercialization rights to satraplatin forEurope and certain other territories. Spectrum licensed worldwiderights to satraplatin from Johnson Matthey PLC. Satraplatin is a nove...

Data Presented at AACR Meeting Shows Peregrine's Immunocytokine Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in Preclinical Studies

...manufacturing capabilities through itswholly owned subsidiary Avid Bioservices, Inc. (<a target="_blank"href="http://www.avidbio.com/">www.avidbio.com ), which providesdevelopment and bio-manufacturing services for both Peregrine andoutside customers. Additional information about Peregrine can befound a...

Data Presented at AACR Meeting Show Peregrine's Bavituximab Equivalent Can Generate Curative Immune Responses as Part of a Vaccine-Like Regimen in Preclinical Models of Aggressive Brain Cancer

...manufacturing capabilities through itswholly owned subsidiary Avid Bioservices, Inc. (<a target="_blank"href="http://www.avidbio.com/">www.avidbio.com ), which providesdevelopment and bio-manufacturing services for both Peregrine andoutside customers. Additional information about Peregrine can befound a...

Data on Higher Dose of Copaxone and Data Showing Copaxone is Most Cost Effective

... is marketed byTeva Neuroscience, Inc., which is a subsidiary of TevaPharmaceutical Industries Ltd. (NASDAQ:TEVA). In Europe,COPAXONE is marketed by Teva Pharmaceutical Industries Ltd.and sanofi-aventis. COPAXONE is a registered trademark ofTeva Pharmaceutical Industries Ltd. Teva Pharmaceutical Industries ...

Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Growth of Both Hormone-Dependent and Hormone-Independent Prostate Cancer by Up to 94 Percent in Preclinical Studies

...manufacturing capabilities through itswholly owned subsidiary Avid Bioservices, Inc. (<a target="_blank"href="http://www.avidbio.com/">www.avidbio.com ), which providesdevelopment and bio-manufacturing services for both Peregrine andoutside customers. Additional information about Peregrine can befound a...

Data Published in Neurology Showed That Higher Dose of Copaxone Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS)

... is marketed byTeva Neuroscience, Inc., which is a subsidiary of TevaPharmaceutical Industries Ltd. (NASDAQ:TEVA). In Europe,COPAXONE(R) is marketed by Teva Pharmaceutical Industries Ltd. andsanofi-aventis. COPAXONE(R) is a registered trademark of TevaPharmaceutical Industries Ltd. Teva Pharmaceutical Industri...

Calando Pharmaceuticals Announces Preclinical Efficacy and Safety Data of Targeted, Systemic Delivery of siRNA at AACR Annual Meeting

...ing siRNA therapeutics company and amajority-owned subsidiary of Arrowhead Research Corporationpresented positiv...com/">www.calandopharma.com ), amajority-owned subsidiary of Arrowhead Research , is using itsproprietary technologies in targeted polymeric delivery systems ...
Other Contentscarnivorecarnivorefixationfixationfixationfixationfixationfixationfixationfixationcarboncarboncarboncarboncarboncarboncarboncarriercarriercarriercarriercarriercarriercarriercarriercarriercartilagecartilagecartilagecartilagecartilagecartilagecartilagedivisiondivisiondivisiondivisiondivisiondivisiondivisionanabolismanabolismnucleusnucleusnucleusnucleusnucleusnucleusnucleusnucleusnucleus
(Date:7/24/2008)...lvania State University College of Medicine, Hersh... of imiquimod, a clinically important immune respo...ctivity, is dependent on the Opioid Growth Factor ...is discovery, reported in the August 08 issue of ...nsights into a widely used drug that may lead to d...
(Date:7/24/2008)...uly 24, 2008) A multi-institutional team of resea...Minnesota Medical School, have developed a powerfu...st method will allow researchers to generate synth...quences for inactivation or repair. , The potenti... director of the Arnold and Mabel Beckman Center f...
(Date:7/24/2008)...008. A fire is currently burning through a study a...r about 2 years ago. Managers used data and analys...) study in the planning, analysis, and implementat... is now active., The Gotchen LSR, lies on the ea...overs about 15,000 acres of the Mount Adams Ranger...
(Date:7/23/2008)...08 One of the reasons people on low-carbohydrate ...take of fructose, a type of sugar that can be made...at UT Southwestern Medical Center. , Dr. Eliza...ion and lead author of a study appearing in a curr...team,s findings suggest that the right type of car...
Breaking Biology News(10 mins):Imiquimod, an immune response modifier, is dependent on the OGF-OGFr signaling pathway 2Consortium develops new method to manipulate genetic material 2Landscape study may offer solutions for fire managers 2Limiting fructose may boost weight loss, UT Southwestern researcher reports 2Limiting fructose may boost weight loss, UT Southwestern researcher reports 3Statement by Oscar S Wyatt Jr 1322 1Statement by Mike Leavitt Secretary of Health and Human Services on the United States China Bilateral Meetings on Food and Drug Safety 1318 1Monsanto Company Signs Share Subscription Agreement With Devgen 594 1Monsanto Company Signs Share Subscription Agreement With Devgen 594 2Monsanto Company Signs Share Subscription Agreement With Devgen 594 3Womens Folic Acid Levels Improving 1312 1Womens Folic Acid Levels Improving 1312 2Womens Folic Acid Levels Improving 1312 3Womens Folic Acid Levels Improving 1312 4
(Date:7/25/2008)... to benefit ALS Therapy Alliance to be presented a...ht, WOONSOCKET, R.I., July 25 /PRNewswire/ -- CVS...ised a record-breaking $4.4 million in just 21 day... for ALS research. This is,the seventh year of the...sed more than $15 million for ALS research. This y...
(Date:7/25/2008)...ds fluid back-up in esophagus can cause immune sys...ay News) -- The first evidence linking gastroesoph...scovered by Duke University Medical Center researc...ns was first noted in the 1970s, and since then st...rcent of asthma patients also experience GERD symp...
(Date:7/25/2008)... New program delivers immediate co...[24-hour telephone access to language interpreters...g multilingual solutions. , ...LLE® http://www.lle-inc.com/index.html [(Lan...ider of interpretation, translation, and language ...
(Date:7/25/2008)... Whether you are an Olympian, Prof..., there are Five Things You Need to Know about Hyd....C. Spine and Sports Center , ...-- America,s premier athletes are heading to Beiji...ng and sacrifice in the hopes of capturing an Olym...
Breaking Medicine News(10 mins):Health News:CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign 2Health News:People With GERD More Likely to Develop Asthma 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 4Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 5
Other TagscoastparkparkparkparkparkeacheacheacheacheachboxespregnanciesOther Tagsasthmatic 2asthmatic 3spell 2iron 2iron 3iron 4iron 5iron 6iron 7neutralizing 2interactive 2